The role of B cells and alloantibody in the host response to human organ allografts (Q35583534)

9 August 2017

1 reference

title

The role of B cells and alloantibody in the host response to human organ allografts (English)

1 reference

9 August 2017

4

Philip F Halloran

1 reference

9 August 2017

Attapong Vongwiwatana

series ordinal

1

1 reference

PubMed ID

14617206

9 August 2017

Adis Tasanarong

series ordinal

2

1 reference

PubMed ID

14617206

9 August 2017

Luis G Hidalgo

series ordinal

3

1 reference

9 August 2017

1 December 2003

1 reference

9 August 2017

Immunological Reviews

1 reference

9 August 2017

196

1 reference

9 August 2017

197-218

1 reference

Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection

9 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Humoral theory of transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Complement C4d in graft capillaries -- the missing link in the recognition of humoral alloreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Extrafollicular antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Lifetime of plasma cells in the bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Visualization of specific B and T lymphocyte interactions in the lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Chemokines and cell migration in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

ICOS is critical for CD40-mediated antibody class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Humoral immunity and long-lived plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Humoral immunity due to long-lived plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

The structural requirements for complement activation by IgG: does it hinge on the hinge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Immunomodulatory functions of murine CR1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Locally produced complement and its role in renal allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Chemokines and their receptors in allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Posttransplant immune monitoring of anti-HLA antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Immunologic monitoring in lung allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Cross-matching in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Clinical significance of anti-endothelial cell antibody in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

The clinical significance of antibody to vascular endothelial cells after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

An association between antibodies specific for endothelial cells and renal transplant failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Pre-transplant anti-epithelial cell antibodies and graft failure after single lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

ABO-incompatibility in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

ABO-incompatible heart transplantation in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Post-transplant renal tubulitis: the recruitment, differentiation and persistence of intra-epithelial T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Peritubular capillary basement membrane reduplication in allografts and native kidney disease: a clinicopathologic study of 278 consecutive renal specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Pathogenesis and treatment of bile duct loss after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Mycophenolate mofetil decreases antibody production after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Immunoadsorption of sensitized kidney transplant candidates immediately prior to surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Overcoming a positive crossmatch in living-donor kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Local synthesis of complement component C3 regulates acute renal transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Call for revolution: a new approach to describing allograft deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

21 January 2018

[Iso-leuko-antibodies]

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

The clinical importance of alloantibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

IL-5 and eosinophils mediate the rejection of fully histoincompatible vascularized cardiac allografts: regulatory role of alloreactive CD8(+) T lymphocytes and IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Expression of heme oxygenase-1 can determine cardiac xenograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Flow cytometry crossmatch: a sensitive technique for assessment of acute rejection in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Posttransplant donor-specific antibody characterization and kidney graft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Postoperative production of anti-donor antibody and chronic rejection in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

An association between posttransplant antibody production and renal transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Antibodies to vascular endothelial cells in chronic rejection of renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Anti-endothelial antibodies and coronary artery disease after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Preliminary report: dramatic rise in renal allograft failure rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Target antigens of post-rejection non-HLA antibodies in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Mechanisms of chronic renal allograft rejection. II. Progressive allograft glomerulopathy in miniature swine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Identification of T helper cell subsets in continuous ambulatory peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Protein A immunoadsorption (i.a.) in renal transplantation patients with vascular rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Multilayering of peritubular capillary is a specific diagnostic criterion for immunologic chronic rejection: does a humoral factor contribute to the pathogenesis of peritubular capillary lesions in chronic rejection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-065X.2003.00093.X

10.1046/J.1600-065X.2003.00093.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14617206